At A Glance
Healthcare marketers are spending record amounts on pharma advertising, but most still can't connect campaign exposure to prescribing outcomes. This article explains why fragmented data, identity, and measurement systems break the link between patient (DTC) and healthcare professional (HCP) audiences, and the infrastructure that closes that gap.Originally published in AdExchanger
Key takeaways
- Pharma digital ad spend is tracking between $22 billion and $26 billion in 2026, yet most brands still can’t connect ad exposure to prescribing behavior.
- DTC and HCP teams need to agree on a shared measurement framework before a campaign launches, not after, so performance can be judged on one standard.
- Experian’s identity infrastructure keeps DTC and HCP data governed separately through two distinct paths while still making cross-audience measurement possible.
- Experian’s Audience Engine connects audience building to activation, giving teams access to premium publisher inventory and a marketplace of 19+ verified health data partners.
Healthcare marketing teams are spending more than ever. Pharma digital ad spend is now tracking between $22 billion and $26 billion in 2026, with connected TV (CTV) overtaking search as the most noticed healthcare ad channel. Yet most brands still can’t draw a straight line from campaign exposure to a filled prescription.
The problem isn’t budget or creative. It’s a structural gap in how healthcare marketers connect data, identity, and measurement across patient (DTC) and healthcare professional (HCP) audiences.
That gap is widening as campaigns grow more complex. A brand running a simultaneous patient (DTC) push and healthcare professional (HCP) engagement program is running two disconnected programs with different data sources, identity schemas, agency relationships, and definitions of success. When a patient sees a CTV ad and their cardiologist receives a targeted digital engagement the same week, almost no brand can confirm that those two exposures happened, let alone measure their combined effect on prescribing behavior.
Why is data fragmentation becoming a bigger challenge for healthcare marketers?
Data fragmentation is becoming a bigger challenge for healthcare marketers because the accuracy pharma brands are paying for in digital media doesn’t match what most measurement stacks can deliver. As pharma shifts spend from linear television to digital channels, the expectation of accuracy comes with it. Brands can no longer accept “we reached the right demographic” as a measurement answer when they are paying programmatic CPMs and expecting outcomes measured in script lift.
The typical healthcare marketer is working with three or four disconnected data environments. Consumer data lives in one place. Claims and National Provider Identifier (NPI) records live in another. Media reporting from the agency is in a third. Analytics and measurement are downstream of all of them, often running on a different timeline. Each handoff introduces the potential for data loss, and those losses compound across a campaign flight.
This creates a reporting picture that tells you what happened in each channel but not what worked across them. That distinction matters enormously when the goal isn’t impressions but activation, adherence, or prescribing behavior.
The missing layer in pharma marketing. Watch our Q&A
Does fixing healthcare data fragmentation mean merging DTC and HCP data together?
No, merging DTC and HCP data together isn’t the answer to healthcare data fragmentation. Healthcare data environments have strict governance requirements, and the separation of DTC and HCP data is both a regulatory and a strategic necessity. Merging DTC and HCP data into a single undifferentiated pool is not a goal worth pursuing.
What healthcare marketers actually need is a shared infrastructure that lets disparate data environments speak a common language without eliminating the boundaries between them. Three elements make that possible:
Experian’s identity infrastructure is built on this principle, acting as a neutral, interoperable workflow layer. For DTC audiences, that means high-fidelity tokenized matching that preserves accuracy from onboarding through activation and into partner-enabled measurement. For HCP audiences, it means deterministic NPI-based resolution using verified professional attributes including specialty, practice location, and professional address. These are two distinct identity paths, governed to keep DTC and HCP data separate while enabling measurement across both.
From onboarding to outcomes
Pharma marketing teams need identity workflows that can support accurate audience creation, governed activation, and partner-enabled measurement without combining DTC and HCP identity paths.
Download our pharma marketing playbook to help your team:
- Plan DTC and HCP identity strategies with clearer separation
- Prepare audiences for activation across approved channels and partners
- Evaluate audience quality, usable reach, and governance
What does a connected view of DTC and HCP audiences look like in healthcare marketing?
A connected view means DTC and HCP audiences in healthcare marketing runs on identity workflows matched to what each requires, deterministic resolution for HCPs and high-fidelity matching for DTC, with both feeding into shared measurement instead of siloed reporting. Building this kind of connected infrastructure isn’t a one-quarter initiative, but three questions show you where your program stands today.
Why is infrastructure the foundation for durable healthcare marketing programs?
Infrastructure is the foundation for durable healthcare marketing programs because it’s what lets audience planning, activation, and measurement function as one connected system instead of three separate handoffs that break down under pressure. As healthcare marketing gets more competitive, regulated, and measurable, that connected system is what keeps campaigns from starting over each time.
A connected view of DTC and HCP audiences in healthcare, with the proper guardrails in place, is a strategic decision about how your brand wants to compete. The technology and the partner ecosystem exist to make it real. The question is whether your marketing organization is structured to take advantage of it.
Ready to build a connected healthcare identity strategy?
Our team works with pharma brands to align identity, audience, and measurement across DTC and HCP programs. If you’re ready to close the gap between data and outcomes, let’s talk.
About the author
Kevin Dunn
Chief Revenue Officer, Experian
Kevin Dunn joins Experian Marketing Services with more than 20 years of leadership experience across marketing and advertising technology, most recently serving as Senior Vice President of Brands and Agencies at LiveRamp. In that role, he led growth across retail, CPG, travel, hospitality, financial services, and healthcare, overseeing new business, account expansion, and channel partnerships.
Kevin is known for building cohesive, accountable teams and leading with optimism, clarity, and a strong sense of shared purpose. His leadership philosophy centers on empowering people, driving positive outcomes for clients and fostering a culture where teams can grow, take smart risks, and succeed together.
FAQs
Most pharma brands can’t connect a CTV ad exposure to a prescribing decision because their DTC and HCP data runs through three or four disconnected environments: consumer data, claims and NPI records, agency media reporting, and downstream analytics. Each handoff between those systems introduces potential data loss, and those losses add up across a campaign flight, leaving brands with channel-level reporting instead of a connected view of what actually moved prescribing behavior.
Building a connected identity strategy doesn’t mean combining DTC and HCP data into one data set. Healthcare data environments carry strict governance requirements, so DTC and HCP data need to stay separate for both regulatory and strategic reasons. A connected identity strategy links those separate environments through interoperable workflows rather than merging them into one data set.
Experian helps pharma brands connect DTC and HCP measurement without merging their data by running two distinct, governed identity paths: high-fidelity tokenized matching for DTC audiences and deterministic NPI-based resolution for HCP audiences, built on verified professional attributes like specialty and practice location. That structure lets brands measure performance across both audiences while keeping the underlying data separate.
The difference between deterministic and probabilistic matching in healthcare marketing comes down to certainty: probabilistic matching can support large-scale DTC reach where some statistical estimation is acceptable, while HCP targeting calls for certainty that only deterministic matching, typically based on verified NPI data, can provide. As healthcare audiences get more specific, the cost of an unverified match rises, which is why HCP resolution leans deterministic.
If a healthcare marketing team’s audience strategy isn’t translating into activation, the first thing to check is whether those audience segments can actually reach live publisher inventory. A lot of audience development happens in a spreadsheet or analytics tool and then stalls at activation because the IDs never connect to real media. Experian’s Audience Engine builds audience creation, onboarding, and activation into one workflow, backed by a marketplace of 19+ verified health data partners.
Latest posts
NEW YORK, June 1, 2016 /PRNewswire/ — Are Traasdahl, CEO and founder of Tapad, the leader in cross-device marketing technology and now a part of Experian, has been named Founder of the Year by the Nordic Startup Awards. The Nordic Startup Awards’ Founder of the Year Award recognizes an individual that has shown exceptional achievements in fundraising, customer growth, financial savvy, and/or leadership throughout the past year. The Nordic Startup Awards evaluates hundreds of players in the startup ecosystem, ranging from investors and founders, to developers and journalists in Denmark, Sweden, Iceland, Norway and Finland. Taking place in two stages, each country selects its nominees for consideration for the regional awards which were held in Iceland on May 31, 2016. Traasdahl is recognized for his continuous investment in Tapad as a whole, as well as his dedication to growing and developing Tapad since founding the company in 2010. He has led Tapad from startup through a steady period of growth resulting in an acquisition by the Telenor Group for $360 million in February 2016. “I am truly honored to be named Founder of the Year by the Nordic Startup Awards, among so many other remarkable leaders in the space,” said Traasdahl. “That said, this has always been a team effort. We started Tapad with the goal of giving employees unprecedented growth opportunities while developing breakthrough solutions for our clients. This is a win for everyone at Tapad who has committed themselves to these principles over the past four-and-a-half years.” Tapad is reinforcing its commitment to fostering entrepreneurship with the launch of their new Propeller Program. Through Propeller, Tapad will host five early-stage companies at Tapad’s New York headquarters for a year to set them up for global expansion. In its inaugural year, the first participants will come from Traasdahl’s native Norway. For more information on the Nordic Startup Awards, please visit: http://www.nordicstartupawards.com. Contact us today
NEW YORK, May 4, 2016 /PRNewswire/ — Tapad, the leader in cross-device marketing technology and now a part of Experian, has been honored with two iMedia ASPY Awards. Announced on May 3rd at the iMedia Summit in Lost Pines, TX, Tapad’s 2016 ASPY Awards include “Best Customer Service” and “Best Mobile Partner.” In 2015, Tapad’s proprietary technology, Tapad Device Graph™, was named “Best New Media Innovation” and Tapad employee Chris Martin was awarded the “Rising Star Award.” The iMedia ASPY Awards – determined exclusively by agency votes – recognize the industry’s top marketing technology, media companies and publishers for outstanding service to agencies. The award for “Best Customer Service” recognizes Tapad’s client services team and their dedication to helping agencies fully understand their consumers’ behavior and achieve the best cross-screen campaign ROI through Tapad’s Campaign Pulse and TV Pulse analytics reporting. The “Best Mobile Partner” win recognizes the abilities of the Tapad Device Graph™ to deliver unified cross-screen solutions for the company’s partners. “We are privileged to have a talented and dynamic group of people on our client services team, and we are honored to be recognized by iMedia Connection and our agency partners,” said Tapad Founder and CEO, Are Traasdahl. “We have always strived to provide the best solutions and the best customer support, so it’s extremely gratifying to be rewarded for our efforts. If our clients and partners are happy, we are happy.” For more information on the iMedia ASPY Awards please visit: http://aspyawards.com. Read the full press release here. Contact us today
Cross-screen marketing tech firm, Tapad, drove unified campaign; partnered with Statiq to measure cross-screen impact on in-store visits LONDON, March 8, 2016 /PRNewswire/ — Carat North completed the UK’s most comprehensive digital campaign with Tapad, the leader in cross-device marketing technology and now a part of Experian. Coupled with location-based audience data from Statiq, this marks the first time a UK-company has measured the impact of unified, cross-screen campaign on in-store visits. Carat North served display and video ads to grocery shoppers for the leading retailer ASDA from August through October. During the campaign, Tapad utilized Statiq’s audience data to measure which users visited a store after being exposed* to the campaign’s ad on multiple devices. The digital campaign demonstrated a lift of 59% for in-store visits when users were exposed to ads on three devices over people who were shown an ad only on onescreen. Those who engaged with the ad were also 411% more likely to visit an ASDA store. Of those who were exposed to an ad, 248% were more likely to visit a store. Impressions served to mobile devices saw the highest success rate with an in-store visit lift of 67%. The campaign leveraged Tapad’s proprietary technology, The Device Graph™, which Nielsen confirmed Tapad’s cross device accuracy to be 91.2%, to serve ads sequentially on connected devices belonging to the same user. CARAT NORTH: “The ability to know which devices belong to our customer, coupled with the ability to deliver the right ad, and right message, wherever they are and on whatever device they’re using, has been something this industry has long needed,” said Steve Thornton, Digital Account Manager, Carat North. “We’re impressed with the results that have come from the work with Tapad and Statiq for this media-first, and look forward to continuing to offer these solutions to clients like ASDA. Matching unified cross-device capabilities with real insights on campaign performance is an invaluable advantage in the marketing world.” TAPAD: “This campaign is a perfect example of the capabilities of cross-device advertising,” said Are Traasdahl, Founder and CEO, Tapad. “In addition to reaching users across devices, we’re able to analyze campaign results and determine how different combinations of ad exposure, creative type or view frequency affected their decision to visit a location.” STATIQ: “As a location data specialist, Tapad is our ideal partner – they are an industry leader and by working with them we are able to determine the impact unified messaging has on real world consumer behaviours,” said Dean Cussell, Co-Founder of Statiq. “We believe this type of analysis will significantly aid brands in optimising future ad spend.” About Carat North Carat North is a leading independent media planning & buying specialist in digital and non-traditional media solutions. Owned by global media group Dentsu Aegis Network, the Carat network is more than 6,700 people in 130 countries worldwide across 170 cities. Carat defined the sector when established as the world’s first media independent in 1968 and is now Europe’s largest media network, a position held for more than 15 years. For more information visit www.carat.co.uk About Tapad Tapad Inc. is a marketing technology firm renowned for its breakthrough, unified, cross-device solutions. With 91.2% data accuracy confirmed by Nielsen, the company offers the largest in-market opportunity for marketers and technologies to address the ever-evolving reality of media consumption on smartphones, tablets, home computers and smart TVs. Deployed by agency trading desks, publishers and numerous Fortune 500 brands, Tapad provides an accurate, unified approach to connecting with consumers across screens. In 2015, Tapad began aggressively licensing its identity management solution, the Tapad Device Graph™, and swiftly became the established gold-standard throughout the ad tech ecosystem. Tapad is based in New York and has offices in Atlanta, Boston, Chicago, Dallas, Detroit,Frankfurt, London, Los Angeles, Miami, Minneapolis, San Francisco and Toronto. TechCrunch called the powerhouse Tapad team “a hell of a list of entrepreneurs who created some of the most valuable online advertising companies of the last decade.” Among Tapad’s numerous awards: EY Entrepreneur of The Year (East Coast) 2014, among Forbes’ Most Promising Companies two year’s running, Deloitte’s Technology Fast 500, Crain’s Fast 50, Entrepreneur 360, Digiday Signal Award, iMedia ASPY Award, and a MarCom Gold Award. Read the full release here. *Tapad utilized Statiq’s audience data to measure which users visited a store during, or within one month of, being exposed to the campaign’s ad on multiple devices. Contact us today